TransCode Therapeutics Insider Trades

RNAZ

Track insider trading activity from TransCode Therapeutics executives and directors. See which insiders are buying and selling RNAZ stock.

Trades Last 12 Months

RNAZ Price

All Insider Trades for TransCode Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Calais Philippe Director
Holding Value $353k 70,000 shares
Last Trade
Jun 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$54.3M 70,000 shares
$776.16
$5.04
Fitzgerald Thomas A Interim Ceo, CFO
Holding Value $3.28M 650,000 shares
Last Trade
Jun 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$505M 650,000 shares
$776.16
$5.04
Manting Erik Director
Holding Value $353k 70,000 shares
Last Trade
Jun 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$54.3M 70,000 shares
$776.16
$5.04
Marquet Magda Director
Holding Value $353k 70,000 shares
Last Trade
Jun 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$54.3M 70,000 shares
$776.16
$5.04
Dudley Robert Michael Chief Executive Officer
Holding Value $909k 180,262 shares
Last Trade
Sep 28, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.46B 98,000 shares
$14,880.32
$5.04
Medarova Zdravka Chief Technology Officer
Holding Value $302k 60,000 shares
Last Trade
Dec 12, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.8B 60,000 shares
$263,894.40
$5.04

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up